Abstract:Background: Polytherapy in neonatal and pediatric patients requiring parenteral nutrition (PN) administration is a challenging task. Due to limited intravenous access, the Y-site administration of medication with PN admixtures is sometimes inevitable. Aim: This review aims to summarize the evidence on the compatibility of the Y-site of intravenous medications and PN admixtures in neonatal and pediatric settings. Methods: A literature review of the PubMed database was conducted. Articles published between January 1995 and November 2023 concerning the compatibility of intravenous medications in pediatric-dose PN admixtures or with intravenous lipid emulsions only were included. Studies concerning the compatibility/stability of the ingredients of PN admixtures and those concerning unapproved medications were excluded. Based on the methodology used, the quality of the research was assessed. Results: A total of fifteen studies were explored. Among fifty-five different drug substances assessed in the research reviewed, 56% (31/55) were found to be compatible, 13% (7/55) were assigned as incompatible, and for 31% (17/55), the data were ambiguous. None of the studies demonstrated an "A" grade (very high quality), and the grades "B", "C", and "D" were assigned to four, six, and five studies, respectively. The compatibility data are presented in two tables, the first concerning the simultaneous administration of medications with 2-in-1 PN formulations (without lipids) and the second, with 3-in-1 formulations (with lipids) and lipid emulsions. Conclusions: This review presents data on compatibilities between intravenously administered medications and PN mixtures intended for neonates and pediatric patients found in the PubMed database. It should be highlighted, however, that this work has some limitations. The clinical decisions on the simultaneous administration of intravenous medication with PN admixtures should be based not only on this review (including assessment of the quality of evidence) but also on manufacturer data, available electronic databases, and incompatibility data for PN admixtures dedicated to adult patients.

Stability and assessment of amino acids in parenteral nutrition solutions

Stability of Certain Amino Acids in a Parenteral Nutrition Solution

Expert consensus on clinical use of compound amino acid injection

Parenteral nutrition compatibility and stability: Practical considerations

Physicochemical Stability of Hospital Parenteral Nutrition Solutions: Effect of Changes in Composition and Storage Protocol

Production and stability study of a hospital parenteral nutrition solution for neonates

Analysis of antibiotic stability in a parenteral nutrition solution

Compatibility and stability of additives in parenteral nutrition admixtures

Evaluation of the Stability of Newborn Hospital Parenteral Nutrition Solutions

Parenteral nutrition compatibility and stability: A comprehensive review

Parenteral amino acid intakes in critically ill children: a matter of convenience

Electron Microscopy for the Stability Assessment of Parenteral Nutrition Admixtures: Focus on Precipitation

Stability of individualized neonatal parenteral nutrition admixtures with fish oil and high calcium content

Stability of all-in-one nutrient solutions mixed with colloid solutions

The all-in-one nutrient solution in parenteral nutrition

Optical Microscopy as a Tool for Assessing Parenteral Nutrition Solution Stability: A Proof of Concept

Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications

Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection

Parenteral nutrition with standard solutions in paediatric intensive care patients

Y-Site Compatibility Studies of Parenteral Nutrition and Other Intravenous Medications in Neonatal and Pediatric Patients: A Review of the Literature Evidence

Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study